EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 89 filers reported holding EPIZYME INC in Q4 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,852,000 | +22.6% | 153,062 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $1,510,000 | -4.2% | 153,494 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $1,576,000 | -7.9% | 153,876 | +8.9% | 0.00% | 0.0% |
| Q1 2016 | $1,712,000 | +10.9% | 141,251 | +46.5% | 0.00% | 0.0% |
| Q4 2015 | $1,544,000 | +24.6% | 96,396 | +0.1% | 0.00% | 0.0% |
| Q3 2015 | $1,239,000 | -47.2% | 96,314 | -1.5% | 0.00% | -33.3% |
| Q2 2015 | $2,346,000 | +192.5% | 97,769 | +128.9% | 0.00% | +200.0% |
| Q1 2015 | $802,000 | +21.3% | 42,721 | +22.0% | 0.00% | 0.0% |
| Q4 2014 | $661,000 | -31.1% | 35,022 | -1.0% | 0.00% | 0.0% |
| Q3 2014 | $959,000 | -44.2% | 35,375 | -35.9% | 0.00% | -50.0% |
| Q2 2014 | $1,719,000 | +303.5% | 55,226 | +195.3% | 0.00% | +100.0% |
| Q1 2014 | $426,000 | +24.9% | 18,700 | +13.9% | 0.00% | 0.0% |
| Q4 2013 | $341,000 | -49.1% | 16,417 | -2.0% | 0.00% | 0.0% |
| Q3 2013 | $670,000 | +58.0% | 16,747 | +11.1% | 0.00% | 0.0% |
| Q2 2013 | $424,000 | – | 15,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |